Innovation Award for CORAT’s COVID-19 antibody development

Innovation Award for CORAT’s COVID-19 antibody development

Braunschweig, September 28, 2020 – The CORAT consortium, a cooperation between Braunschweig University and YUMAB GmbH has received the Innovation Award of the State of Lower Saxony that is endowed with 20.000 Euros. The prize acknowledges the contributions of both partners in the first steps of the development of a curative COVID-19 antibody drug. The transition into clinical development of the drug candidate will be pursued by the YUMAB spin-out CORAT Therapeutics GmbH in collaboration with industry partners.

Read YUMAB’s press release (English)
Read the press information of the University Braunschweig (German)

Contact

YUMAB GmbH
Dr. Thomas Schirrmann, CEO
Phone: +49-531 481170-0
Email: info@yumab.com